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1 Introduction
The improper use of antibiotics in the treatment of bacterial
infections has resulted in the appearance of spreading resistant
strains [1]. Among them, Staphylococcus aureus has been
recognized as an important pathogen both in community-
acquired and healthcare-associated infections. S. aureus has
successfully become resistant to practically all antibiotics, and
this is a serious clinical problem in the world today [2].
Therefore, the search for new pharmaceuticals alternative to
antibiotics and design of new treatment approaches of staph-
ylococcal infections are important tasks.
Lysostaphin is a zinc metalloenzyme which has a specific
lytic action against S. aureus. Glycylglycine endopeptidase
specifically cleaves the glycine–glycine bonds, unique to the
interpeptide cross-bridge of the S. aureus cell wall. Due to its
unique specificity, lysostaphin could have high potential in the
treatment of antibiotic-resistant staphylococcal infections [3].
It is known that lysostaphin shows synergistic effects in its
antistaphylococcal activity when used in combination with
conventional antibiotics [4–6], antimicrobial peptides [7],
and proteins [8]. This makes it possible to reduce the amount
of the used enzyme and retain high antistaphylococcal activ-
ity. Since antibacterial proteins lead to acquired resistance in
Staphylococcus strains to a much lesser degree, theymay have
significant advantages over traditional antibiotics [9]. It was
found previously that high-molecular weight chitosan
(HMWC) can enhance lysostaphin-mediated cell lysis of
S. aureus cells [10]. However, HMWC has several disadvan-
tage such as poor solubility and high viscosity. So, we studied
the effect of low molecular weight chitosan (LMWC) on the
lysis of living staphylococcal cells by lysostaphin.
2 Experimental
2.1 Materials and Methods
2.1.1 Preparation of Low Molecular Weight Chitosan
We used crab HMWCwith an average molecular weight (Mυ)
of 600 kD and a deacetylation degree of 85% (ZAO
Bioprogress, Russia). High-molecular weight chitosan was
hydrolyzed in hydrochloric acid at 70 °C, and LMWC hydro-
chloride was precipitated with ethanol and dried in vacuum
over sodium hydroxide as described [11]. Chitosan solutions
were filtrated through a 0.22 μm poresize syringe filter
(Millipore, Swinnex) and stored at 4 °C until usage.
2.1.2 Chitosan Characteristics
The medium-viscosity molecular weight of chitosan was cal-
culated by Mark-Coon-Houwink equation for chitosans with
different degree of deacetylation as described previously [12];
the deacetylation degree was evaluated according to [13].
2.1.3 Microorganism
S. aureus ATCC 35591 was stored in a semiliquid meat pep-
tone agar (MPA) at 4 °C. For the growth of bacteria, 5%
suspension of bacterial culture was added in a 100 mL flask
containing 20mL ofmeat peptone broth (MPB) and incubated
with shaking at 150 rev/min for 18 h at 37 °C.
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